Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Lemaitre Vascular Inc’s stock clocked out at $83.37, down -0.14% from its previous closing price of $83.49. In other words, the price has decreased by -$0.14 from its previous closing price. On the day, 0.28 million shares were traded. LMAT stock price reached its highest trading level at $84.55 during the session, while it also had its lowest trading level at $81.81.
Ratios:
To gain a deeper understanding of LMAT’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.51 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 28.56. For the most recent quarter (mrq), Quick Ratio is recorded 11.45 and its Current Ratio is at 13.22. In the meantime, Its Debt-to-Equity ratio is 0.49 whereas as Long-Term Debt/Eq ratio is at 0.48.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 12 ’25 when Jasinski Lawrence J sold 976 shares for $92.78 per share. The transaction valued at 90,553 led to the insider holds 4,773 shares of the business.
Roberts David B sold 10,815 shares of LMAT for $999,173 on Aug 11 ’25. The President and Director now owns 17,976 shares after completing the transaction at $92.39 per share. On Aug 08 ’25, another insider, Ross Bridget A, who serves as the Director of the company, sold 2,500 shares for $94.00 each. As a result, the insider received 235,000 and left with 2,916 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LMAT now has a Market Capitalization of 1891331328 and an Enterprise Value of 1733908352. As of this moment, Lemaitre’s Price-to-Earnings (P/E) ratio for their current fiscal year is 35.88, and their Forward P/E ratio for the next fiscal year is 32.27. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.65. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.85 while its Price-to-Book (P/B) ratio in mrq is 4.99. Its current Enterprise Value per Revenue stands at 7.199 whereas that against EBITDA is 24.007.
Stock Price History:
The Beta on a monthly basis for LMAT is 0.67, which has changed by -0.21964669 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, LMAT has reached a high of $107.86, while it has fallen to a 52-week low of $71.42. The 50-Day Moving Average of the stock is -4.84%, while the 200-Day Moving Average is calculated to be -4.43%.
Shares Statistics:
It appears that LMAT traded 165.56K shares on average per day over the past three months and 201980 shares per day over the past ten days. A total of 22.68M shares are outstanding, with a floating share count of 20.86M. Insiders hold about 8.05% of the company’s shares, while institutions hold 92.91% stake in the company. Shares short for LMAT as of 1763078400 were 1175225 with a Short Ratio of 7.10, compared to 1760486400 on 1224447. Therefore, it implies a Short% of Shares Outstanding of 1175225 and a Short% of Float of 7.000000000000001.
Dividends & Splits
With its trailing 12-month dividend rate of 0.76, LMAT has a forward annual dividend rate of 0.80. Against a Trailing Annual Dividend Yield of 0.009102887. The stock’s 5-year Average Dividend Yield is 0.87.
Earnings Estimates
Current recommendations for the stock of the company come from 10.0 analysts. The consensus estimate for the next quarter is $0.62, with high estimates of $0.66 and low estimates of $0.54.
Analysts are recommending an EPS of between $2.52 and $2.3 for the fiscal current year, implying an average EPS of $2.42. EPS for the following year is $2.59, with 10.0 analysts recommending between $2.83 and $2.39.
Revenue Estimates
In. The current quarter, 11 analysts expect revenue to total $62.98M. It ranges from a high estimate of $64.6M to a low estimate of $61.8M. As of. The current estimate, Lemaitre Vascular Inc’s year-ago sales were $55.72MFor the next quarter, 11 analysts are estimating revenue of $65.8M. There is a high estimate of $67.4M for the next quarter, whereas the lowest estimate is $64.66M.
A total of 11 analysts have provided revenue estimates for LMAT’s current fiscal year. The highest revenue estimate was $251M, while the lowest revenue estimate was $247M, resulting in an average revenue estimate of $248.26M. In the same quarter a year ago, actual revenue was $219.86MBased on 11 analysts’ estimates, the company’s revenue will be $270.77M in the next fiscal year. The high estimate is $276.28M and the low estimate is $264M.
